CSL Share Price

The latest CSL share price, updated daily:

CSL Financial Summary

CSL is an Australian medical products company with major facilities in Australia, Germany, Switzerland and the United States. It specializes in human plasma products, vaccines, pharmaceuticals and research and development. It employs more than 10,000 people in 27 countries worldwide.

Fiscal Year Ending June 30
For more complete information visit http://www.csl.com.au
Unless stated otherwise revenues are stated in million $A

2008 2007

Total Revenue 3,794 3,310
Sales Revenue 3,557 3,172
R & D Investment 225 191
Pre-tax Profit 702 539
Capital Investment 218 205
Total Assets 30/6 4,695 4,200
Total Equity 2,806 2,269
Net tangible assets per share at 30 June ($) 3.44 2.44
Weighted average number of shares (million) 550 548
Basic earnings per share (cents) 127.6 98.5
Dividend per share (cents) 46.0 34.7
Latest CSL News